Article Abstract
Recent studies of autism spectrum disorder (ASD) and childhood apraxia of speech (CAS) have resulted in conflicting conclusions regarding the comorbidity of these disorders on phenotypic grounds. In a nuclear family with two dually affected and one unaffected offspring, whole-exome sequences were evaluated for single nucleotide and indel variants and CNVs. The affected siblings but not the unaffected sibling share a rare deleterious compound heterozygous mutation in WWOX, implicated both in ASD and motor control. In addition, one of the affected children carries a rare deleterious de novo mutation in the ASD candidate gene RIMS1. The two affected children but not their unaffected sibling inherited deleterious variants with relevance for ASD and/or CAS. WWOX, RIMS1, and several of the genes harboring the inherited variants are expressed in the brain during prenatal and early postnatal development. Results suggest compound heterozygosity as a cause of ASD and CAS, pleiotropic gene effects, and potentially additional, complex genetic effects.
For more information, read the study here.
Mawi DNA Technologies Partners with GenoBank.io To Tokenize Our Groundbreaking…...
October 14, 2024 – We are thrilled to announce that Mawi DNA Technologies has officially partnered with READ MORE
Mawi DNA Partners with Tempus AI and Tally Health™ to…...
October 7, 2024 – Customers frequently ask what swabs are compatible with our iSWAB® non-invasive sample collection technology. Although most swab types can be used with our system, incl...
READ MORESolena Ag and Mawi DNA Partner to Revolutionize Soil Health…...
January 4, 2024 – Solena Ag, a leader in soil health insights for sustainable agriculture, and Mawi DNA Technologies (Mawi DNA), a pioneer in high-integrity sample collection and storage, today anno...
READ MORE
